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Several reports have described the potential effects of natural compounds as anti-cancer agents in vitro as well as
in vivo. The aim of this study was to evaluate the anti-cancer effect of Limoniastrum guyonianum aqueous gall
extract (G extract) and luteolin in the human cervical cancer HeLa cell line, and, if so, to clarify the underlying
mechanism. Our results show that G extract and luteolin inhibited cell proliferation and induced G2/M cell cycle
arrest in a concentration and time-dependent manner. Both natural products induced programmed cell death as
confirmed by the presence of hypodiploid G0/G1 cells. These effects are associated with an up-regulation of the
expression of the tumor suppressor gene p16INK4A and a down-regulation of the expression of the anti-apoptotic
actor UHRF1 and its main partner DNMT1. Moreover, G extract- and luteolin-induced UHRF1 and DNMT1 down-
regulation is accompanied with a global DNA hypomethylation in HeLa cell line. Altogether our results show that G
extract mediates its growth inhibitory effects on human cervical cancer HeLa cell line likely via the activation of a
p16INK4A -dependent cell cycle checkpoint signalling pathway orchestrated by UHRF1 and DNMT1 down-regulation.
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Natural products derived from plants have received ex-
tensive attention as potential anti-cancer agents over few
decades. Most of current anti-cancer drugs such as
camptothecin, vincristine, taxol, etoposide and paclitaxel
are plant-derived compounds [1,2]. These bioactive phy-
tochemicals are known to exert their anti-cancer activity
through different mechanisms, including altered carcino-
gen metabolism, induction of DNA repair systems, im-
mune activation, suppression of cell cycle progression
and induction of apoptosis. Several studies have shown
that natural products rich in polyphenols have strong
chemopreventive and chemotherapeutic properties in* Correspondence: marc.mousli@unistra.fr
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reproduction in any medium, provided the ordifferent types of cancer cells [3,4]. Flavonoids, poly-
phenolic compounds found in plant-derived dietary com-
ponents, exhibit multiple biological activities, including
anticarcinogenic activity. Luteolin, one of the most effect-
ive flavonoids, can delay or block the development of can-
cer cells in vitro and in vivo via inhibition of tumor cell
proliferation, induction of cell cycle arrest and apoptosis
by inhibiting enzymes involved in cell activation such as
phosphodiesterases kinases and DNA topoisomerases [5].
Methylation of CpG islands is an important component
of the epigenetic code and a number of genes become
abnormally methylated during tumorigenesis. A hyper-
methylation of the tumor suppressor gene p16INK4A at its
CpG-rich promoter regions and subsequent inactivation of
the p16INK4A gene have been reported in several haemato-
logical and solid cancers [6,7]. This hypermethylation
targets the expression of specific genes involved in the DNA
damage response including, the retinoblastoma protein
(pRB) [8]. More recently, many studies have reported that. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Krifa et al. Journal of Experimental & Clinical Cancer Research 2013, 32:30 Page 2 of 10
http://www.jeccr.com/content/32/1/30UHRF1 serves as a fidelity factor for the maintenance of the
DNA methylation pattern throughout cell duplication
[9,10]. The Set and Ring Associated domain (SRA domain)
of UHRF1 has the unique feature to recognize a particular
state of DNA, i.e., hemi-methylated. The SRA–DNA inter-
action may serve as an anchor to keep UHRF1 at a hemi-
methylated CpG site where it recruits the DNMT1 for DNA
methylation maintenance [9,11]. Thus, UHRF1 plays a
fundamental role in the inheritance of the DNA epigenetic
marks from the mother cell to the daughter cells. It also
appears that preventing the transmission of these marks
via knock-down of UHRF1 leads to an activation of
pro-apoptotic pathways [9,12-16]. In agreement with this
hypothesis, UHRF1 down-regulation has been shown to
inhibit cell growth and induces apoptosis of colorectal can-
cer through p16INK4A up-regulation [17]. Some bioactive
plants components have been shown to have cancer inhib-
ition activities by reducing DNA hypermethylation of key
cancer-causing genes through their DNA methyltransferase
(DNMT) inhibition properties [18]. In this context,
recently we found that the epigallocatechin-3-gallate
(EGCG), a natural anti-cancer drug induces G1 cell arrest
and apoptosis in Jurkat cells by down-regulating UHRF1
and DNMT1 expression, with subsequent up-regulation of
p16INK4A gene [19].
L. guyonianum has been used in traditional medicines
to treat gastric infections. It has also been employed as
an anti-bacterial drug in the treatment of bronchitis
[20]. L. feei has been similarly used in the treatment of
bronchitis and stomach infections [21]. Previous investi-
gations revealed that methanol extract from L. feei leaves
contained potential anti-fungal constituents that could
be employed against Candida albicans and anti-bacterial
constituents useful against E. coli [22]. More recently,
our laboratory demonstrated that L. guyonianum aque-
ous gall extract was able to induce splenocyte prolifera-
tion and to stimulate macrophage activation [23].
Chemical investigation of Limoniastrum genus has been
reported in literature. Indeed, bioguided fractionation of
leaves extract from Limoniastrum feei led to the isolation
of several polyphenolic constituents such as Gallic acid,
Epigallocatechin gallate, Quercetin and Myricetin [24]. A
subsequent article noted that ethyl acetate extract of L.
guyonianum contained gallocatechin, epigallocatechin,
and epigallocatechin-3-O-gallate [25]. Several groups have
reported that epigallocatechin gallate exhibited antitumor
effects that were discovered from various cancer cell lines,
animal models and clinical studies [26]. For example,
in vivo studies showed that epigallocatechin gallate admin-
istration decreased H1299 xenograft tumor growth [27].
Furthermore, myricetin treatment significantly inhibited
the tumor growth on T24 bladder cancer xenografts model
[28]. In the same way, it was demonstrated that gallic acid
plays a critical role as an anticancer agent in vivoby decreasing MNNG/HOS xenograft tumor growth in
Balb/C mice [29].
The aim of this study was to determine, in HeLa cervical
cancer cell line, whether Limoniastrum guyonianum aque-
ous gall extract and luteolin, one of the most common fla-
vonoids, could target UHRF1 and DNMT1 expression with
subsequent cell cycle arrest and apoptosis via up-regulation
of p16INK4A gene. Our results show that G extract and
luteolin cause G2/M cell cycle arrest and trigger apoptosis
likely through the inhibition of UHRF1/DNMT1 tandem
expression, followed by an up-regulation of p16INK4A.
Materials and methods
Materials
Limoniastrum guyonianum samples were collected from
El Hamâ at Gabbes (a region situated in southern Tunisia).
Dr. Fethia Skhiri (Department of Botany, Higher Institute of
Biotechnology, University of Monastir) performed sample
identification and verification according to the Tunisian
Guide on Flora [30]. A voucher specimen (#L.g-10.09) was
preserved for future reference. Luteolin (> 90% of purity)
was purchased from Extrasynthese (Genay, France). 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide
(MTT) was from Euromedex (Mundolsheim, France),
propidium iodide (PI), Tris Buffered Saline with tween 20
(TBST) and dimethylsulfoxide (DMSO) from Sigma-
Aldrich (St. Quentin Fallavier, France). Dulbecco’s Modified
Eagle’s Medium (DMEM), fetal calf serum (FCS), trypsin
and L-glutamine were purchased from Invitrogen Life
Technologies (Cergy Pontoise, France). Folin-Ciocalteu phe-
nol reagent was obtained from BDH laboratory (Poole, Eng-
land). Sodium carbonate (Na2CO3) was purchased from
Acros Organics (Geel, Belgium). Nitrite sodium (NaNO2)
and aluminum chloride (AlCl3) were procured from Aldrich
(Steinheim, Germany).
Preparation of plant extract
The collected gall samples were shade-dried, powdered,
and then stored in a tightly closed container for further
use. When needed, powdered gall (100 g) was extracted
in boiling water (1 L) for 15–20 min and after filtration,
the aqueous extract was frozen and then lyophilized and
kept at 4°C. The total aqueous extract concentrate yield
(per gram dried plant material) was determined using
the formula: 100 x weight (g) of dried extract/dry-weight
(g) of plant material. The actual percentage yield in this
study was 17.8%. From this material, extract solutions
containing different concentrations from 100 to 300 μg/ml
were then prepared for use in the evaluation of their cyto-
toxic and pro-apoptotic effects on HeLa cells. The poly-
phenol content of L. guyonianum gall aqueous extract was
quantified by the Folin-Ciocalteau method [31,32] and was
expressed as gallic acid equivalent. Aliquots of test sample
(100 μl) were mixed with 2.0 ml of 2% Na2CO3 and
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of 100 μl of 50% Folin-Ciocalteau phenol reagent, the reac-
tion tube was incubated for 30 min at room temperature,
and finally absorbance was read at 720 nm. A known vol-
ume of the extract was placed in a 10 ml volumetric flask to
estimate flavonoid content [33]. After addition of 75 μl of
NaNO2 (5%), 150 μl of freshly prepared AlCl3 (10%), and
500 μl of NaOH (1 N), the volume was adjusted with dis-
tilled water until 2.5 ml. After 5 min incubation, the total ab-
sorbance was measured at 510 nm. Quercetin was used as a
standard for constructing a calibration curve.
The method described by [34] was used for the deter-
mination of tannin content of samples. Extraction of
tannins was achieved by dissolving 5 g of sample in 50
ml of distilled water in a conical flask, allowing the mix-
ture to stand for 30 min with shaking the flask at 10 min
intervals, and then centrifuging at 5000 g to obtain a
supernatant (tannin extract). The extract was diluted to
100 ml in a standard flask using distilled water. Five mil-
liliters of the diluted extract and 5 ml of standard tannic
acid (0.1 g/L) were measured into different 50 ml volu-
metric flasks. One milliliter of Folin-Denis reagent was
added to each flask followed by 2.5 ml of saturated so-
dium carbonate solution. The solutions were made up to
the 50 ml mark with distilled water and incubated at
room temperature (20–30°C) for 90 min. The absorption
of these solutions was measured against the reagent
blank (containing 5 ml distilled water in the place of the
extract or the standard tannic acid solution) at 760 nm
wavelength. Tannin content was calculated in triplicates
as: sample reading/standard reading × 20 [35].
Cell culture
The human cervical cancer cell line HeLa was obtained
from the American Type Culture Collection (Rockville,
Maryland, USA) and maintained in a humidified incubator
with 5% CO2 at 37°C, and grown in DMEM (Dulbecco’s
Modified Eagle’s Medium). The medium was supplemented
with 10% (v/v) fetal calf serum (FCS, Biowhitaker, Lonza,
Belgium), 2 mM glutamine, 100 U/ml penicillin and 50
mg/ml streptomycin (Sigma St. Louis, MO).
Cell proliferation and apoptosis assays
Cells were seeded in 96-well cell culture plates at a dens-
ity of 0.5 × 104 cells/well, grown for 24 hours and ex-
posed to different concentrations of G extract or luteolin
for 24 hours. Cell proliferation rate was then assessed
by colorimetric assay using the CellTiter 961 Aqueous
One Solution Cell Proliferation Assay (MTT), following
the manufacturer’s recommendations. Early and late
apoptosis were monitored by flow cytometry (Guava
PCA-96 Merck/Millipore, Molsheim, France). To dis-
criminate between negative and positive events in the
analysis, a non-stained control sample from eachculture condition always accompanied acquisition of
the stained cells to define their cut off. Gates were
drawn around the appropriate cell populations using a
forward scatter (FSC) versus side scatter (SSC) acquisition
dot plot. Late apoptotic cells are double labelled by
Annexin V and 7-AAD (Guava Nexin Reagent kit Merck/
Millipore). Cytometers performances are checked weekly
using the Guava easyCheck Kit 4500–0025 (Merck/
Millipore/Guava Hayward, CA, USA).
Cell cycle analysis
Cells were seeded in 96-well cell culture plates at a dens-
ity of 0.5 × 104 cells/well and grown for 24 hours, then
exposed to different concentrations of G extract or
luteolin for 24 hours. Cells were then washed with
phosphate-buffered saline (PBS), trypsin detached then
fixed with paraformaldehyde (1%). After 30 min incuba-
tion at room temperature, 5 μl of propidium iodide was
added in each well (1 μg/ml). Cellular DNA content was
assessed by capillary cytometry (Guava EasyCyte 96
Plus). Data were analyzed on the Guava CytoSoft™ Ex-
press Pro software (Merck/Milli pore/Guava Tech).
CytoSoft Express Pro was used to identify the three cell
cycle phases and calculate relevant statistics, including
population percentages (subG1, G0/G1, S and G2/M
phases).
Quantification of DNA methylation
HeLa cells were treated with G extract (200 μg/ml) or
luteolin (25 μM) for 48 hours. DNA was purified using
QIAamp® DNA Kit. The content of methylated DNA was
determined using 200 ng of DNA from untreated cells,
treated cells with G extract or luteolin, as described by the
manufacturer; Sigma’s Imprint® Methylated DNA Quantifi-
cation Kit.
Western blot analysis
HeLa cells (6 × 105) were seeded into 6-well cell culture
plates and grown for 24 hours. Cells were treated with
different concentrations of G extract or luteolin for 24
and 48 hours. The cells were then harvested, centrifuged
to discard the DMEM medium, washed with cold PBS
(phosphate buffered saline), resuspended in RIPA buffer
(25 mM Tris, pH 7.6, 150 mM NaCl, 1% NP-40, 1% so-
dium deoxycholate and 0.1% SDS; Sigma–Aldrich, USA)
containing protease inhibitors. Equal amounts of total
protein were separated on 10–12% polyacrylamide gel
and electrophoretically transferred to a nitrocellulose
membrane. After blocking with 5% non-fat dry milk or
3% BSA (Bovine Serum Albumin) and tween 20 in PBS,
the nitrocellulose membranes were incubated with either
a mouse monoclonal anti-UHRF1 antibody (Proteogenix,
Oberhausbergen, France), a mouse monoclonal anti-
DNMT1 (clone 60B1220.1, Proteogenix), and a rabbit
Figure 1 Aqueous gall extract and luteolin induce UHRF1 and
DNMT1 down-regulation and p16INK4A up-regulation in HeLa
cells. HeLa cells were exposed to G extract (A) or luteolin (B) at the
indicated concentrations for 24 and 48 hours. DNMT1, UHRF1
p16INK4A were analyzed by western blotting. Results were
representative of three separated experiments.
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CA) according to the manufacturer’s instructions (4°C,
overnight). Membranes were thereafter incubated with
the appropriate horseradish peroxidase-conjugated sec-
ondary antibody (diluted to 1:10,000 for anti-mouse anti-
bodies and 2: 10,000 for anti-rabbit antibody) at room
temperature for 45 minutes. The membranes were then
washed with TPBS five times. Signals were detected by
chemiluminescence using the ECL Plus detection system
(Amersham, GE Healthcare UK Limited).
Statistical analysis
Data were analyzed with student’s t-test and presented
as mean value ± S.E.M of three independent measure-
ments in separate experiments.
Results
Aqueous gall extract content
Aqueous gall extract from L. guyonianum was the sub-
ject of a chemical study with the aim of having a global
idea in their composition. The metabolites contents of the
tested extract are presented in Table 1. Quantitative phyto-
chemical analysis showed that the extract contained an
important quantity of flavonoids, polyphenols, and tannins.
In fact, 1 mg of G extract was equivalent to 85 μg of gallic
acid and 460 μg of quercetin. The higher content of tan-
nins was also recorded in the extract with 77.5 mg/100 g.
Aqueous gall extract and luteolin induce UHRF1 and
DNMT1 down-regulation and p16INK4A up-regulation
associated with a reduced global DNA methylation
The present study was undertaken to investigate the ef-
fect of G extract on the expression of UHRF1/DNMT1
tandem known to be involved in gene expression regula-
tion via DNA methylation [9,11]. HeLa cells were treated
with different concentrations (100, 200 and 300 μg/ml)
of G extract for 24 and 48 hours. As shown in Figure 1A,
treating the cells with 300 μg/ml of G extract for 24
hours induced a significant decrease in the expression of
UHRF1, DNMT1 and this expression was abolished after
48 hours of treatment. Cells treatment with 200 μg/ml
of G extract also induced a significant decrease of
UHRF1 and DNMT1 expressions but only after expos-
ure for 48 hours whereas at 100 μg/ml there was no ef-
fect. Several studies have been shown that UHRF1Table 1 Phytochemical composition of aqueous gall (G)
extract from L.guyonianum
Metabolites Extract content (μg)
Flavonoids (Quercetin equivalent) 460 ± 14
Polyphenols (Gallic acid equivalent) 85 ± 6
Tannis (mg/100g tannic acid) 77 ± 5
Values are means ± S.E.M. of three independent experiments.negatively regulates the expression of the p16INK4A
tumor suppressor gene [19,36]. Thus, we aimed to know
whether G extract and luteolin could affect the expres-
sion of p16INK4A in HeLa cell line. Our results showed
that G extract induced a dose dependently up-regulation
of p16INK4A expression (Figure 1A). This effect was asso-
ciated with the G extract-induced down-regulation of
UHRF1 and DNMT1 expression (Figure 1A). Quantita-
tive phytochemical analysis of G extract showed that fla-
vonoids are the major compounds present in this
extract, which suggest that G extract-induced effect on
UHRF1 and DNMT1 expression could be attributed, at
least in part to these compounds. In order to obtain evi-
dence for this hypothesis, the effect of luteolin, a dietary
flavonoid on the expression of UHRF1, DNMT1 and
p16INK4A proteins has been investigated. As shown in
Figure 1B, treating cells with luteolin induced a dose and
time down-regulation of UHRF1. Indeed, UHRF1 ex-
pression was significantly decreased after 24 hours treat-
ments and approximately disappeared at 50 μM after 48
hours (Figure 1B). For DNMT1, only 50 μM induced a
significant decrease of DNMT1 expressions after incuba-
tion for 24 hours. After treatment of cells for 48 hours,
DNMT1 expression was significantly decreased at 25
μM and totally abolished at 50 μM whereas at 12.5 μM
there was no effect (Figure 1B).
Next, we wanted to determine whether the reduced
UHRF1 and DNMT1 levels in G extract and luteolin-
treated HeLa cells are correlated with an effect on genomic
DNA methylation. We assessed global genomic DNA
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assay. As shown in Table 2, a general decrease in genomic
DNA methylation was evidenced by both natural products.
Indeed, our results demonstrate that G extract and luteolin
inhibited DNA methylation as compared to untreated cells
(Table 2) with percent inhibition of 42.4% ± 1.6% and
46.5% ± 1.1% in the presence of G extract and luteolin, re-
spectively. Altogether, these findings showed that both G
extract and luteolin were able to decrease UHRF1 and
DNMT1 expression leading to a reduced genomic DNA
methylation which could induce the re-expression of the
p16INK4A tumor suppressor gene.
G extract and luteolin inhibit cell growth and induce cell
cycle arrest of HeLa cells
Considering that p16INK4A tumor suppressor gene is a
downstream target of UHRF1 and a negative regulator
of cell proliferation [17,36], we then wanted to deter-
mine whether G extract- or luteolin-induced up-
regulation of p16INK4A leads to cell proliferation inhib-
ition and cell cycle arrest. As illustrated in Figure 2, ex-
posure of HeLa cells to G extract (A) or luteolin (B)
inhibited cell proliferation in a dose- and time-
dependent manner. The IC50 values were determined
graphically and the inhibition percentages were calcu-
lated. Inhibition of proliferation of HeLa cells, by G ex-
tract, reached a maximum of 79.6% and 59.7% at a
concentration of 300 μg/ml after 48 and 24 hours of in-
cubation, respectively (Figure 2A). IC50 values were 170
μg/ml and 140 μg/ml of G extract after 24 and 48 hours
treatment, respectively. Interestingly, G extract had no
effect on normal human keratinocytes when cells were
treated with similar concentrations for 24 and 48 hours
(Figure 2C). This suggests that G extract specifically tar-
gets cancer cells.
Luteolin was also able to induce cytotoxicity in HeLa
cells (Figure 2B) with an IC50 value of 21.8 μM after 24
hours. At 50 μM, luteolin decreased proliferation of
HeLa cells by 83.8% and 85.9% after 24 hours and 48
hours of incubation, respectively. These results indicateTable 2 Effects of aqeous gall extract and luteolin on
global methylated DNA in HeLa cells
Average of absorbance (nm) Methylated DNA (% of control)
MC 0.662 ± 0.030 259.90* ± 4.9
C 0.283 ± 0.001 100.00
G200 0.152 ± 0.003 53.53* ± 1.52
L25 0.163 ± 0.005 57.60* ± 2.29
Total DNA was isolated from HeLa cancer cells using QIAamp® DNA Kit. the
content of methylated DNA was determined using 200 ng of DNA from
untreated cells (C), treated cells with 200 μg/ml of G extract (G200 or with 25
μM of luteolin(L25) for 48 hours and the commercial methylated control (MC)
(Imprint Methylated DNA Quantification Kit) Values are means ± S.E.M. of three
independent experiments. Statistically significant, *P < 0.001 (versus the
untreated cells).
Figure 2 Aqueous gall extract and luteolin inhibit HeLa cell
proliferation. HeLa cells and primary cultured human foreskin
keratinocytes were treated with different concentrations of G extract
(A and C) or luteolin (B) for 24 and 48 hours. Cell proliferation rate
was assessed by colorimetric measurements using the MTT assay.
The absolute value obtained for each G extract- or luteolin -treated
sample is expressed in a second step as percent relative to the
corresponding absolute value obtained for the untreated sample
and set at 100. Values are means±S.E.M. of three independent
experiments. Statistically significant, *P < 0.05, **P < 0.01, ***P < 0.001
(versus the corresponding untreated group).
Figure 3 Aqueous gall extract and luteolin arrest cell cycle
progression. Cells were treated with different concentrations of
aqueous gall extract (A) or luteolin (B) for 24 hours. Cell cycle
distribution was assessed by a capillary cytometry detection assay.
Cell number in G0/G1, S or G2/M phase was determined and
expressed as percent relative to the total cell number. Values are
means ± S.E.M. of three experiments. Statistically significant, *
P < 0.05, **P < 0.01, (versus the corresponding untreated group).
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growth inhibition of HeLa cells.
Because cell proliferation is a consequence of the pro-
gression of the cells through the different phases of the
cell cycle, we next determined the effects of G extract
and luteolin on the cell cycle distribution (Figure 3).
HeLa cells were incubated in the presence and/or ab-
sence of different concentrations of G extract (A) or
luteolin (B) for 24 hours. Treatment of HeLa cells with
the extract caused an increase in G2/M peaks and a de-
crease in the S and G0/G1-phases fraction in a
concentration-dependent manner (Figure 3A). Indeed,
the percentage of cells in the G0/G1 phase was de-
creased from 50.1% (control) to 32.3% at 300 μg/ml
whereas an accumulation of the cell population was ob-
served in the the G2/M from 7.5% in untreated cells to
19.6% at the same concentration. Similarly to G extract,
treatment of HeLa cells with luteolin caused an increase
in G2/M phase and a decrease in the G0/G1-phase frac-
tion in a concentration-dependent manner (Figure 3B).
It appears therefore that G extract is able to inhibit the
proliferation of Hela cells by promoting cell cycle arrest
at the G2/M phase.
G extract and luteolin induce apoptosis in HeLa cells
UHRF1 down-regulation has been shown to induce
apoptosis in cancer cells [37]. Moreover, it has recently
been demonstrated that UHRF1 down-regulation in-
hibits cell growth and induces apoptosis of colorectal
cancer through p16INK4A up-regulation [17]. Thus, we
next investigated whether G extract- or luteolin-induced
UHRF1 down-regulation and p16INK4A up-regulation
could induce apoptosis in HeLa cells. As shown in Fig-
ure 4, increasing concentrations of both products are as-
sociated with increasing number of apoptotic cells.
Indeed, the percentage of apoptotic cells significantly
increased from 8.6 (control) to 46.4% at 200 μg/ml and
54.4% at 300 μg/ml of G extract (Figure 4A), and to
37.2% at 25 μM and 49.2% at 50 μM of luteolin
(Figure 4B). As expected, the calculated half-maximal
effect of G extract on apoptosis was 170 μg/ml for 24
hours of treatment. Hence, these data were consistent
with those obtained from cell proliferation assays
(Figure 2). As a next step, cell cycle phase distribution
analysis was focused on the detection of specific G0/G1
apoptotic cells; as shown in Figure 4, increasing concen-
trations of G extract led to increasing number of hypo-
diploid sub-G0/G1 cells (Figure 4C). Thus, G extract
induced an increase in sub-G1 peak in a concentration-
dependent manner ranged from 10.2% to 27.6% at
concentrations of 100 and 300 μg/ml, respectively. At 50
μM of luteolin, an increment from 8.1% (control) 23.5%
was observed in subG1 phase (Figure 4D). Finally, all
these results suggest the occurrence of apoptosis inHeLa cells related to UHRF1 down-regulation and
p16INK4A up-regulation when exposed to G extract or
luteolin.
Discussion
Several studies have reported that plant-derived natural
products have cancer chemopreventive and chemothera-
peutic properties. Polyphenol-rich fruits and vegetables
Figure 4 Aqueous gall extract and luteolin induce HeLa apoptosis. Cells were treated with different concentrations of aqueous gall extract
(A, C) or luteolin (B, D) for 24 hours. Cell apoptosis rate was assessed by capillary cytometry using the Annexin V-FITC staining assay. The number
of apoptotic cells is expressed as percent relative to the total cell number. Cell number in subG0/G1, phase was determined and expressed as
percent relative to the total cell number. Values are means ± S.E.M. of three experiments. Statistically significant, *P < 0.05, **P < 0.01, ***P < 0.001
(versus the corresponding untreated group).
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several cancers [3,38]. The aim of the present study was
to determine the anti-proliferative and pro-apoptotic
potential of G extract, a source rich in polyphenols
(63%, data not shown) on the human cervical cancer
HeLa cell line and if so, to characterize the mechanism
involved. The present study indicates that G extract
markedly inhibited proliferation of human cervical
cancer HeLa cell line in a concentration-dependent
manner. The G extract-induced growth inhibitory
effect is associated with an arrest of the cell cycle
progression in G2/M phase as shown by the cell
phase distribution. In addition, G extract promoted
in a concentration-dependent manner these cells
towards apoptosis as indicated by annexin V labelling
and by the increase in hypodiploid sub-G0/G1 cell
population. In order to characterize the mechanism
involved in the anti-proliferative and pro-apoptotic
signalling pathway activated by G extract, the expres-
sion of the anti-apoptotic UHRF1, its main partner
DNMT1 and the cell cycle inhibitor p16INK4A was
determined. The present findings indicate that G ex-
tract caused a marked and concentration-dependent
up-regulation of p16INK4A suggesting that this cell
cycle checkpoint regulator is a key mediator of thepro-apoptotic activity of G extract in HeLa cells. In
addition, G extract also caused a parallel down-
regulation of the anti-apoptotic UHRF1 and its part-
ner DNMT1. Similarly, the natural anti-cancer drug,
epigallocatechin-3-gallate has been shown to induce
p16INK4A re-expression-dependent pro-apoptotic pathway
via the down-regulation of UHRF1 in Jurkat cells [19].
Moreover, a recently published study has shown that
UHRF1 depletion in cancer cells causes G2/M cell cycle
arrest and apoptosis accompanied with phosphorylation of
cyclin-dependent kinase 1 (CDK1) [37] which is in agree-
ment with our present data. UHRF1 is an oncogene pro-
tein known to bind to methylated DNA and to recruit the
DNMT1 to regulate tumor suppressor gene expression
including p16INK4A [38]. Here, we showed that G extract
decreased the expression UHRF1 as well as DNMT1. This
effect was accompanied with an up-regulation of tumor
suppressor gene p16INK4A. As UHRF1 is a negative regula-
tor of p16INK4A expression involving DNMT1 [19,36], our
results suggest that the mechanism of action of G extract
involves, at least in part, a down-regulation of UHRF1
with subsequent down-regulation of DNMT1 leading to
an up-regulation of p16INK4A gene inducing G2/M cell
cycle arrest. In agreement with this hypothesis, we have
recently shown that curcumin inhibited melanoma cell
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cells at the G2/M-phase with decreased expression of
UHRF1 and DNMT1 and enhanced expression of p21, a
p16INK4A -homolog [39]. Furthermore, because of CDK1
is required for progression of cells from the G2 phase
into and through mitosis, down regulation of UHRF1
after cell treatment with G extract might also induce
CDK1 phosphorylation and causes the G2/M cell cycle
arrest and apoptosis as previously described in UHRF1
depleted cells [37].
Considering that G extract has a high quantity of
polyphenolic compounds, we hypothesized that these
products could be involved in the anti-proliferative and
pro-apoptotic effects on HeLa cells. So, in order to obtain
evidence for this hypothesis, the dietary flavonoid luteolin
has been used in this study. Several studies have shown
that flavonoids have anti-cancer effect on cancer cells
involving several mechanisms including, cancer cells elim-
ination, cell-cycle progression inhibition and induction of
apoptosis [40-42]. Our results indicate that luteolin
inhibits cell proliferation, arrests cell cycle progression
and induces apoptosis in HeLa cells. A similar mechanism
has also been involved in the effect of luteolin on cell cycle
and apoptosis in HeLa cancer cells [43]. It has been shown
that luteolin is able to induce G2/M cell cycle arrest and
apoptosis in human oesophageal squamous cell carcinoma
cell line (KYSE-510) cells in a dose- and time-dependent
manner through p73-dependent up-regulation of p21waf1
and down-regulation of cyclin B1 [44]. In the present
study, we found that luteolin induced cell cycle arrest and
apoptosis in HeLa cells associated with a decrease in the
expression of UHRF1 and DNMT1 and an increase in the
expression of p16INK4A. As p73 is a negative regulator of
UHRF1 [45] and a positive regulator of p16INK4A [46],
luteolin-induced UHRF1/ p16INK4A deregulation observed
in HeLa cells could be a result of p73 up-regulation.
Similarly, Aronia melanocarpa juice, rich resource in
polyphenols has been shown to induce p73-dependent
pro-apoptotic pathway involving UHRF1 down-regulation
in the p53- deficient acute lymphoblastic leukemia Jurkat
cell line [3]. UHRF1 plays an important role in cancer pro-
gression through epigenetic mechanisms. However, several
reports indicated that UHRF1 contributes to silencing of
tumor suppressor genes by recruiting DNMT1 to their
promoters. Conversely, demethylation of tumor suppres-
sor gene promoters has been ascribed to some anti-cancer
natural products such as epigallocatechin-3-O-gallate
[47,48]. Our data showed that both luteolin and G extract
were able to down regulate UHRF1 and DNMT1
expressions in HeLa cells. This effect was associated with
re-expression of tumor suppressor gene p16INK4A. Unex-
pectedly, p16INK4A was totally repressed at the higher
concentration (50 μM) of luteolin which could result from
p16INK4A protein denaturation and/or degradation at thisconcentration. In agreement with this suggestion, luteolin
has been shown to up-regulate p21 expression at low
concentrations and to down-regulate its expression at high
concentrations [49].
Emerging evidence suggests that dietary natural prod-
ucts are involved in epigenetic modifications, especially
DNA methylation leading to reduce the risk of cancer
[50,51]. Here, we examined the effect of G extract and
luteolin on the global DNA methylation in HeLa cells.
Our results reveal that the levels of global DNA
methylation were reduced in HeLa cells by about 42.4%
and 46.5% in the presence of G extract and luteolin for
two days, respectively. This effect was associated with
a sharp decrease in the expression of DNMT1. The
inhibition of DNA methylation as well as UHRF1 and
DNMT1 down-regulation and the re-expression of
p16INK4A may be ascribed to several compounds found
in G extract. Preliminary results of phytochemical
screening revealed the presence of polyphenols. Further-
more, it was reported that L. guyonianum ethyl acetate
extract contains epigallocatechin-3-O-gallate [52]. This
biologically active substance could induce p16INK4A
re-expression through UHRF1 and DNMT1 depletion
[19]. Our data support the idea that the DNA methyla-
tion process can be reversed in cancer cells by bioactive
phytochemicals. Indeed, it has been shown that apple
polyphenols has potent DNA demethylation activity in
colorectal cancers by reducing DNMT1 expression with
a subsequent activation of TSGs such as p16INK4A [53].
In the same way, it has been shown that grape seed
proanthocyanidins, an anti-carcinogenic product, caused
a reduced global DNA methylation in skin cancer cells
related to a decrease in the level of DNMT1 and an
increase in the level of p16INK4A [18]. Considering that
UHRF1 binds to methylated promoter of p16INK4A [54]
and that UHRF1 interacts with DNMT1 and regulates
its expression [36], it is likely that G extract and luteolin
induce in cervical cancer cells a down-regulation of
UHRF1 with subsequent decrease of DNMT1 expression
causing demethylation of p16INK4A promoter.
Conclusion
This is the first report which shows that G extract in-
duces apoptosis related to a reduced DNA methylation
likely by acting on the epigenetic integrator UHRF1 and
its main partner DNMT1. By using cervical cancer HeLa
cell line, we have shown that G extract inhibits cell
proliferation and arrests cell cycle progression at the
G2/M phase which could be through re-expression the
tumor suppressor gene p16INK4A.
Abbreviations
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